It also inhibits the proliferation of gastric and non-small-cell lung cancer cells by blocking STAT3 binding to the MUC4 promoter region and by suppressing EGFR phosphorylation through Grb2 downregulation, respectively [90,91]. Here, MUC4 is linked to non-small cell lung carcinoma.